Be part of the knowledge.™

Oncology and Hematology

1889

LikeLikedUnlike

Episodes 196-210 of 256

Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC
MinuteCE®
Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC
- Aiwu Ruth He, MD, PhD
  Peer
1.00 program credits
Emerging First-Line ICI Combination Regimens in Patients With Unresectable HCC
MinuteCE®
Emerging First-Line ICI Combination Regimens in Patients With Unresectable HCC
- Ghassan K. Abou-Alfa, MD
  Peer
1.00 program credits
Case Consult: Treatment Options for an Unresectable HCC Patient Who Has Esophageal Varices
MinuteCE®
Case Consult: Treatment Options for an Unresectable HCC Patient Who Has Esophageal Varices
- Aiwu Ruth He, MD, PhD
  Peer
1.00 program credits
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
CME/CE Broadcast Replay
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
- Jennifer Caudle, DO
  Peer
- Patricia A. Mangan, RN, MSN, APRN-BC
  Peer
1.00 credits
When Adjuvant Immunotherapy for Resectable NSCLC May Be the Better Approach
MinuteCE®
When Adjuvant Immunotherapy for Resectable NSCLC May Be the Better Approach
- Jessica S. Donington, MD, MSCR
  Peer
0.50 program credits
MinuteCE®
A Personalized Approach to Perioperative Immunotherapy in Early-Stage Resectable NSCLC
- Mark Awad, MD, PhD
  Peer
- Jessica S. Donington, MD, MSCR
  Peer
0.50 credits 4 episodes
advertisement
Tailoring Your Perioperative Immunotherapy Approach for Resectable NSCLC
MinuteCE®
Tailoring Your Perioperative Immunotherapy Approach for Resectable NSCLC
- Mark Awad, MD, PhD
  Peer
- Jessica S. Donington, MD, MSCR
  Peer
0.50 program credits
Predicting Response to Neoadjuvant and Perioperative Chemoimmunotherapy
MinuteCE®
Predicting Response to Neoadjuvant and Perioperative Chemoimmunotherapy
- Mark Awad, MD, PhD
  Peer
0.50 program credits
Perioperative Immunotherapy for Resectable NSCLC: Evaluating Approved and Emerging Approaches
MinuteCE®
Perioperative Immunotherapy for Resectable NSCLC: Evaluating Approved and Emerging Approaches
- Mark Awad, MD, PhD
  Peer
0.50 program credits
APPlexus Hot Topics 2024: Clinical Updates on Non-Covalent BTK Inhibitors in CLL and MCL
CME/CE
APPlexus Hot Topics 2024: Clinical Updates on Non-Covalent BTK Inhibitors in CLL and MCL
- Sandra E. Kurtin, PhD, ANP-BC, FAPO
  Peer
- Beth Faiman PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO
  Peer
1.00 credits
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting
CME/CE
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting
- Matthew Lunning, DO, FACP
  Peer
0.50 credits
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
MinuteCE®
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
- Peter E. Newburger, MD
  Peer
1.00 program credits
advertisement
WHIM Syndrome: A Misguided Immune System!
MinuteCE®
WHIM Syndrome: A Misguided Immune System!
- Peter E. Newburger, MD
  Peer
1.00 program credits
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
MinuteCE®
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
- Jacob R. Bledsoe, MD
  Peer
1.00 program credits
WHIM Syndrome Treatment: We Can Do Better!
MinuteCE®
WHIM Syndrome Treatment: We Can Do Better!
- Jolan Walter, MD, PHD
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy

Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

Diagnosis and Management of Metastatic PDAC

TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure

A Practical Guide to Prescribing in HF

Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA